Nature Reviews Cancer

Papers
(The H4-Index of Nature Reviews Cancer is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Computing brain metastasis impact723
Fructose takes a detour to feed cancer694
Combining spatial transcriptomics and AI to enhance brain tumour diagnosis498
Combinatorial strategies to target RAS-driven cancers494
Implementing practice-changing progress for managing cancer of unknown primary476
Emerging strategies to investigate the biology of early cancer437
Claudin proteins as emerging therapeutic targets for solid tumours386
Oncofetal reprogramming in tumour development and progression378
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment327
INVADEseq to study the intratumoural microbiota at host single-cell resolution318
Exploiting metabolic cell death for cancer therapy305
Mapping the prostate cell family tree301
Fighting cancer with fat292
Reply to ‘Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies’280
The recruitment of metastasis-associated monocytes269
3D chromatin architecture as a predictor of somatic mutations in cancer genomes268
Connie J. Eaves (1944–2024)264
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies261
Translating premalignant biology to accelerate non-small-cell lung cancer interception255
Avoiding cancer through collective behaviour254
The evolution of cancer and ageing: a history of constraint229
Tertiary lymphoid structures as hubs of antitumour immunity225
How medical anthropology can contribute to cancer research223
Author Correction: Fighting rare cancers: lessons from fibrolamellar hepatocellular carcinoma221
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel215
Epithelial and stromal co-evolution and complicity in pancreatic cancer206
Nanoreceptors take down mutant p53205
Impersonating neurons201
Tumour EVPs disrupt liver function196
AACR 2025194
Measuring HLA disruption using MHC Hammer192
Gut microbes produce novel genotoxic metabolites187
Persistence is key186
Thelpers? More like Ttroublemakers186
Dendritic cells rise and shine182
Removing barriers to address sex differences in anticancer drug toxicity175
Moonlighting functions of glucose metabolic enzymes and metabolites in cancer172
How chemokines organize the tumour microenvironment168
No mutation, tumour initiation162
Defining a ‘cells to society’ research framework for appendiceal tumours161
Rethinking ovarian cancer III: the past decade and future directions159
Natural killer cells in antitumour adoptive cell immunotherapy157
3D bioprinted cancer models: from basic biology to drug development153
Bone voyage: immune crosstalk sets sail145
B-ring sterols to the rescue140
Visualizing intratumoural heterogeneity with EpicMIBI139
Double trouble for the tumour glycocode133
Identifying spatial cellular structures with SPACE-GM132
In-depth organoid profiling of pancreatic cancer125
Environmental endocrine disruptors: rethinking the origins of early-onset ER+ breast cancer124
Context-dependent synthetic lethality — an emerging precision therapeutic approach122
Leveraging the replication stress response to optimize cancer therapy114
Metabolic interplays between the tumour and the host shape the tumour macroenvironment114
Opportunities and challenges of targeting cGAS–STING in cancer112
The immune microenvironment of colorectal cancer105
The path to leptomeningeal metastasis105
Linking cell mechanical memory and cancer metastasis103
Enhancer and metabolic rewiring by KMT2C–COMPASS or KMT2D–COMPASS family loss in cancer creates druggable vulnerabilities101
Regulatory T cells in the tumour microenvironment101
Dynamics and specificities of T cells in cancer immunotherapy97
Encoding spatial tumour dynamics with Starfysh95
Understanding and addressing race disparities in childhood cancer outcomes95
Race influences the tumour microbiome95
Deciphering the cancer genome and epigenome93
ER stress sparks nerve pain85
The link between vitamin D and prostate cancer83
Being in the zone83
Re-routing IgE for cancer therapy80
Stem cells as an essential mediator of the exercise–tumorigenesis link77
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research74
Polygenic scores in cancer71
0.087683916091919